Carbamazepine
- Product NDC
- 29033-019
- 11-digit product format
- 290330019
- Labeler code
- 29033
- Product ID
- 29033-019_9fcd6487-e123-44ca-a48f-3aa2e5858979
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- carbamazepine
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Nostrum Laboratories, Inc.
- Application
- ANDA076697
- Marketing category
- ANDA
- Marketing start
- 2020-02-17
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 29033-019-12 | Carbamazepine | 120 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 120 | | 10 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CARBAMAZEPINE | ACTIVE INGREDIENT | 33CM23913M | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| CARBAMAZEPINE | ACTIVE MOIETY | 33CM23913M | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| D&C RED NO. 28 | INACTIVE INGREDIENT | 767IP0Y5NH | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| ETHYLCELLULOSE (20 MPA.S) | INACTIVE INGREDIENT | BJG0S321QY | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| OLEIC ACID | INACTIVE INGREDIENT | 2UMI9U37CP | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 29033-019 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 10 | Legacy NDC, 1 package rows | 20240216_fbca2152-0022-47a5-a1ea-58950b45bcbf.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 29033-019-12 | 29033001912 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (29033-019-12) | 2020-02-17 | 0000-00-00 | No | No | Current |